PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Diclofenac sodium - Pain & inflammation - musculoskeletal
PAD Profile : Diclofenac sodium - Pain & inflammation - musculoskeletal
Keywords :
NSAIDs, rheumatism, PNMP, osteoarthritis
Brand Names Include :
Voltarol, Defenac, Dicloflex, Flamrase, Diclozip, Fenactol, Diclomax, Motifene
Traffic Light Status
Status 1 of 4.
Status :
Green (see narrative)
Important
Formulations :
- Tablets
Important Information :
Ibuprofen or naproxen are the preferred NSAIDS.
Diclofenac for use if 1st-line options are ineffective / not tolerated.
Restriced at Trusts to Rheumatology only.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 4.
Status :
Non Formulary
Important
Formulations :
- Modified release capsules
- Modified release tablets
Important Information :
Ibuprofen or naproxen are the preferred NSAIDS.
Standard release diclofenac may be considered if 1st-line NSAIDs are ineffective / not tolerated.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 3 of 4.
Status :
Green
Formulations :
- Suppositories
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 4 of 4.
Guidelines
No guidelines returned.
Other Drugs
- Celecoxib
- Diclofenac sodium
- Naproxen
- Etoricoxib
- Ibuprofen
- Naproxen
- Meloxicam
- Aceclofenac
- Diclofenac potassium
- Indometacin
- Nabumetone
- Etodolac
- Ketoprofen
- Mefenamic acid
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
07 August 2019
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
A stepped approach to pain management is recommended. Paracetamol is considered a 1st line option for the treatment of pain. Consider initiation of oral NSAID (ibuprofen or naproxen) as an adjunct to paracetamol if required. Diclofenac or celecoxib (first line COX 2) may be considered as alternatives when ibuprofen and naproxen are ineffective / not tolerated. See the guidelines attached for further information
Associated BNF Codes
10. Musculoskeletal and Joint Diseases
10.01.01. Non-steroidal anti-inflammatory drugs